Online citations, reference lists, and bibliographies.
← Back to Search

NANOTECHNOLOGY AND HUMAN HEALTH: SCIENTIFIC EVIDENCE AND RISK GOVERNANCE

M. Martuzzi, S. Hansen, Khara Grieger
Published 2011 · Business, Political Science

Cite This
Download PDF
Analyze on Scholarcy
Share
Background: At the Fifth European Ministerial Conference of Environment and Health of 2010, the health implications of nanotechnology were listed among the key EH challenges in Europe. Besides the ...
This paper references
10.1007/S11051-006-9185-3
Evaluation of nanoparticle emission for TiO2 nanopowder coating materials
Li-Yeh Hsu (2006)
The big down: atomtech: technologies converging at the nanoscale
ETC Group (2003)
Characterising the potential risks posed by engineered nanoparticles – A second UK Government Research Report
DEFRA (2007)
10.1016/J.TOX.2005.05.007
Ultrafine titanium dioxide particles in the absence of photoactivation can induce oxidative damage to human bronchial epithelial cells.
Jia-Ran Gurr (2005)
10.1016/j.addr.2012.09.015
Nanoparticulate systems for brain delivery of drugs.
J. Kreuter (2001)
10.1093/annhyg/men058
Exposure to manufactured nanostructured particles in an industrial pilot plant.
E. Demou (2008)
10.1056/NEJM198102053040602
Herpes simplex encephalitis: vidarabine therapy and diagnostic problems.
R. Whitley (1981)
10.1166/JNN.2007.922
Nanotechnology and health safety--toxicity and risk assessments of nanostructured materials on human health.
Surya Singh (2007)
10.1016/j.scitotenv.2008.12.025
Health effects of exposure to carbon nanofibers: systematic review, critical appraisal, meta analysis and research to practice perspectives.
A. Genaidy (2009)
10.1016/j.reprotox.2008.06.008
Kinetics of gold nanoparticles in the human placenta.
P. Myllynen (2008)
10.1021/BI0260334
Amyloid fibril formation by a synthetic peptide from a region of human acetylcholinesterase that is homologous to the Alzheimer's amyloid-beta peptide.
M. Cottingham (2002)
10.1529/BIOPHYSJ.106.094318
Probing the outer mitochondrial membrane in cardiac mitochondria with nanoparticles.
V. Salnikov (2007)
10.1038/nature02263
Protein degradation and protection against misfolded or damaged proteins
A. Goldberg (2003)
10.1007/S11051-008-9459-Z
Airborne nanoparticle exposures associated with the manual handling of nanoalumina and nanosilver in fume hoods
S. Tsai (2009)
10.1016/J.SCITOTENV.2007.10.010
Estimation of cumulative aquatic exposure and risk due to silver: contribution of nano-functionalized plastics and textiles.
Sabine A Blaser (2008)
10.1021/ES7029637
Exposure modeling of engineered nanoparticles in the environment.
Nicole C. Mueller (2008)
10.1091/MBC.01-06-0308
Nuclear pore complex is able to transport macromolecules with diameters of about 39 nm.
N. Pante (2002)
10.1080/15459620490502242
Number Size Distribution, Mass Concentration, and Particle Composition of PM1, PM2.5, and PM10 in Bag Filling Areas of Carbon Black Production
T. Kuhlbusch (2004)
10.1166/JNN.2006.194
The interaction and toxicity of multi-walled carbon nanotubes with Stylonychia mytilus.
Y. Zhu (2006)
Why risk assessment is not enough to protect public health: rationale for a precautionary approach to science and policy
J Tickner (2007)
No nano in Magic Nano
G Elvin (2006)
Silver nanotechnologies and the environment: old problems or new challenges? Washington, DC, Project on Emerging Nanotechnologies, Woodrow Wilson International Center for Scholars
SN Luoma (2008)
Development of mammalian embryos exposed to mixed-size nanoparticles.
S. Bosman (2005)
10.1080/15459620600912280
Particle Characteristics in the Reactor and Pelletizing Areas of Carbon Black Production
T. Kuhlbusch (2006)
10.1164/RCCM.200506-865OC
Do inhaled carbon nanoparticles translocate directly into the circulation in humans?
N. Mills (2006)
10.1021/ES060589N
Titanium dioxide (P25) produces reactive oxygen species in immortalized brain microglia (BV2): implications for nanoparticle neurotoxicity.
T. Long (2006)
10.1080/17435390701314720
Assessing exposure to airborne nanomaterials: Current abilities and future requirements
A. Maynard (2007)
10.1080/10473289.2006.10464545
Health Effects of Fine Particulate Air Pollution: Lines that Connect
J. Chow (2006)
10.1016/S0166-2236(99)01431-9
Unbiased stereology?
J. Hedreen (1999)
Nanoparticle exposure and occupational lung disease – six expert perspectives on a new clinical study
AD Maynard (2009)
10.1161/HC0402.104118
Passage of Inhaled Particles Into the Blood Circulation in Humans
A. Nemmar (2002)
Comparison of risk assessment approaches for manufactured nanomaterials
S Rocks (2008)
10.1159/000131080
Assessment of Quantum Dot Penetration into Intact, Tape-Stripped, Abraded and Flexed Rat Skin
L. Zhang (2008)
10.1007/BF02064184
Uptake and translocation of microparticles in small intestine
G. Hodges (2005)
10.1023/A:1025548512438
Broader Societal Issues of Nanotechnology
M. Roco (2003)
10.4209/AAQR.2008.01.0001
Airborne Nanoparticle Release Associated with the Compounding of Nanocomposites Using Nanoalumina as Fillers
C. Tsai (2008)
10.1289/ehp.8871
Nanoparticles: Health Effects—Pros and Cons
M. Gwinn (2006)
10.1080/00222930701314932
Cellular responses to nanoparticles: Target structures and mechanisms
K. Unfried (2007)
10.1164/AJRCCM/145.3.600
Increased mortality in Philadelphia associated with daily air pollution concentrations.
J. Schwartz (1992)
EU nanotechnology R&D in the field of health and environmental impact of nanoparticles
EC (2008)
Some figures about nanotechnology R&D in Europe and beyond
EC (2005)
10.1093/OCCMED/KQL051
Manufacture and use of nanomaterials: current status in the UK and global trends.
R. Aitken (2006)
10.1016/J.JAEROSCI.2008.10.006
Method for the characterization of the abrasion induced nanoparticle release into air from surface coatings
Manuel Vorbau (2009)
10.1016/J.IJPHARM.2003.10.038
Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge.
A. Kohli (2004)
10.1165/AJRCMB/6.5.535
Pulmonary retention of ultrafine and fine particles in rats.
J. Ferin (1992)
10.1002/ANDP.19053220607
Uber einen die Erzeugung und Verwandlung des Lichtes betreffenden heuristischen Gesichtspunkt
A. Einstein (1905)
10.1111/j.2042-7158.1990.tb07033.x
Nanoparticle Uptake by the Rat Gastrointestinal Mucosa: Quantitation and Particle Size Dependency
P. Jani (1990)
10.1006/TAAP.1999.8793
Silica binds serum proteins resulting in a shift of the dose-response for silica-induced chemokine expression in an alveolar type II cell line.
E. Barrett (1999)
10.1098/rsif.2009.0252.focus
Nanoparticles, human health hazard and regulation
A. Seaton (2009)
10.1016/S0300-483X(00)00277-8
Reactive oxygen species mediated membrane damage induced by fullerene derivatives and its possible biological implications.
J. P. Kamat (2000)
10.1038/206433b0
Airborne Particles
C. Davies (1965)
10.1289/EHP.6000
Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage.
N. Li (2003)
10.1093/TOXSCI/KFM169
Nanotechnology safety concerns revisited.
S. Stern (2008)
10.1007/s11051-009-9829-1
Redefining risk research priorities for nanomaterials
Khara Grieger (2010)
10.1038/nmat2442
Understanding biophysicochemical interactions at the nano-bio interface.
A. Nel (2009)
New study seeks to link seven cases of occupational lung disease with nanoparticles and nanotechnology
AD Maynard (2009)
10.1080/10408440601177780
Grey Goo on the Skin? Nanotechnology, Cosmetic and Sunscreen Safety
G. Nohynek (2007)
Daily mortality and fine and ultrafine particles in Erfurt, Germany part I: role of particle number and particle mass.
H. Wichmann (2000)
10.1007/s10646-008-0210-4
Categorization framework to aid exposure assessment of nanomaterials in consumer products
S. Hansen (2008)
Current and future predicted environmental exposure to engineered nanoparticles
ABA Boxall (2008)
10.1126/science.1156995
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Catherine Dostert (2008)
10.1001/JAMA.287.9.1132
Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution.
C. Pope (2002)
10.1016/S0262-4079(08)62208-3
How war débris could cause cancer
Oliver Tickell (2008)
10.1007/s00109-004-0629-x
Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots
Jasmina Lovrić (2004)
Review of the federal strategy for nanotechnology-related environmental, health, and safety research
National Academy of Sciences (2008)
10.1002/JPS.1143
Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles.
J. F. Hillyer (2001)
10.1042/BJ2290529
Transcytosis and paracellular movements of horseradish peroxidase across liver parenchymal tissue from blood to bile. Effects of alpha-naphthylisothiocyanate and colchicine.
P. Lowe (1985)
10.1002/(SICI)1099-1263(1998090)18:5<307::AID-JAT508>3.0.CO;2-K
Cytotoxicity, pro‐oxidant effects and antioxidant depletion in rat lung alveolar macrophages exposed to ultrafine titanium dioxide
F. Afaq (1998)
Nanotechnology risk governance: recommendations for a global, coordinated approach to the governance of potential risks
IRGC (2007)
10.1016/j.envpol.2008.08.004
Synthetic TiO2 nanoparticle emission from exterior facades into the aquatic environment.
R. Kaegi (2008)
10.1016/J.PORGCOAT.2008.01.008
The interaction of modern sunscreen formulations with surface coatings
P. J. Barker (2008)
10.1146/annurev.pharmtox.47.120505.105237
Drug targeting to the brain.
A. G. de Boer (2007)
10.1021/NL0710710
Comparative pulmonary toxicity assessments of C60 water suspensions in rats: few differences in fullerene toxicity in vivo in contrast to in vitro profiles.
C. Sayes (2007)
10.1289/ehp.10327
Meeting Report: Hazard Assessment for Nanoparticles—Report from an Interdisciplinary Workshop
J. Balbus (2007)
The assessment of different metrics of the concentration of nano (ultrafine) particles in existing and new industries
HSE (2006)
Industry should take lead with media when an event like a recall occurs
P Glaza (2010)
10.1016/J.TOX.2006.11.002
Pulmonary toxicity study in rats with three forms of ultrafine-TiO2 particles: differential responses related to surface properties.
D. Warheit (2007)
10.26616/nioshpub2010112c
Approaches to Safe Nanotechnology Managing the Health and Safety Concerns Associated with Engineered Nanomaterials
Nanotrees (2009)
10.1023/B:JMSM.0000021122.49966.6D
Detection of micro- and nano-sized biocompatible particles in the blood
A. Gatti (2004)
10.1289/EHP.5999
Skin as a route of exposure and sensitization in chronic beryllium disease.
S. Tinkle (2003)
10.1111/J.1530-9290.2008.00031.X
Informing Environmental Decision Making by Combining Life Cycle Assessment and Risk Analysis
J. A. Shatkin (2008)
10.1079/PNS2001134
Fine and ultrafine particles of the diet: influence on the mucosal immune response and association with Crohn's disease.
M. Lomer (2002)
10.1021/ES703043C
Characterization of airborne particles during production of carbonaceous nanomaterials.
B. Yeganeh (2008)
Strategy for nanotechnology-related environmental, health and safety research
NNI (2008)
10.1021/NL0489586
The Differential Cytotoxicity of Water-Soluble Fullerenes
C. Sayes (2004)
10.1093/TOXSCI/KFG243
Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation.
C. Lam (2004)
Risk Assessment of Products of Nanotechnologies
M. Marinovich (2009)
Nanotechnologies: a preliminary risk analysis on the basis of a workshop organized in Brussels on 1–2 March 2004 by the Health and Consumer Protection Directorate General of the European Commission
EU (2004)
Philosophical transactions of the Royal Society of London. B
HighWire Press (1886)
10.1073/pnas.0701250104
Nucleation of protein fibrillation by nanoparticles
S. Linse (2007)
10.1080/15459620701683871
Identification and Characterization of Potential Sources of Worker Exposure to Carbon Nanofibers During Polymer Composite Laboratory Operations
M. Methner (2007)
Magic Nano recall
D Pescovitz (2006)
10.1093/TOXSCI/KFJ122
Penetration of intact skin by quantum dots with diverse physicochemical properties.
Jessica P. Ryman-Rasmussen (2006)
10.1021/ES900692E
Quantitative analysis of fullerene nanomaterials in environmental systems: a critical review.
C. Isaacson (2009)
10.1063/1.3067253
De Re Metallica
Georgius Agricola (1951)
10.1002/j.1460-2075.1993.tb05850.x
H2O2 and antioxidants have opposite effects on activation of NF‐kappa B and AP‐1 in intact cells: AP‐1 as secondary antioxidant‐responsive factor.
M. Meyer (1993)
10.1007/S11051-008-9499-4
Exposure to nanoscale particles and fibers during machining of hybrid advanced composites containing carbon nanotubes
D. Bello (2009)
10.1038/nature01663
Chaperonin-mediated stabilization and ATP-triggered release of semiconductor nanoparticles
C. Walle (2003)
10.1016/0014-5793(96)00812-5
Novel harmful effects of [60]fullerene on mouse embryos in vitro and in vivo
T. Tsuchiya (1996)
The appropriateness of the risk assessment methodology in accordance with the Technical Guidance Documents for new and existing substances for assessing the risks of nanomaterials, 21–22 June 2007
SCENIHR (2007)
10.1080/08958370801942238
Monitoring Multiwalled Carbon Nanotube Exposure in Carbon Nanotube Research Facility
J. Han (2008)
10.1098/rsta.2000.0682
Epidemiological evidence of the effects of ultrafine particle exposure
H. Wichmann (2000)
10.1056/NEJM196510072731501
Smoking in relation to atherosclerosis of the coronary arteries.
O. Auerbach (1965)
10.1080/17435390902725914
Nano-silver – a review of available data and knowledge gaps in human and environmental risk assessment
S. Wijnhoven (2009)
10.1002/etc.135
Possibilities and limitations of modeling environmental exposure to engineered nanomaterials by probabilistic material flow analysis.
F. Gottschalk (2010)
10.1021/NL062464M
Effects of mechanical flexion on the penetration of fullerene amino acid-derivatized peptide nanoparticles through skin.
J. Rouse (2007)
Nanotechnologies — Terminology and definitions for nano-objects — Nanoparticle, nanofibre and nanoplate
ISO (2008)
10.1007/BF01038248
To The Editor
Peter Pucill (1986)
10.1016/S0140-6736(02)11281-5
Effect of air-pollution control on death rates in Dublin, Ireland: an intervention study
L. Clancy (2002)
10.1164/AJRCCM.159.6.9808078
Identification and substance P content of vagal afferent neurons innervating the epithelium of the guinea pig trachea.
D. Hunter (1999)
10.1093/toxsci/kfp265
The biological mechanisms and physicochemical characteristics responsible for driving fullerene toxicity.
H. Johnston (2010)
10.1098/rsta.2000.0681
Ultrafine particles: mechanisms of lung injury
K. Donaldson (2000)
Nanotechnology: small matter, many unknowns
Swiss Re (2004)
10.1016/j.ddtec.2005.05.019
Nanoparticle uptake by the oral route: Fulfilling its potential?
A. Florence (2005)
10.1016/S0169-409X(02)00120-5
Distribution of sunscreens on skin.
J. Schulz (2002)
10.1016/S0306-4522(97)00324-2
Identification and neuropeptide content of trigeminal neurons innervating the rat nasal epithelium
D. Hunter (1998)
10.1016/S0140-6736(95)90173-6
Particulate air pollution and acute health effects
A. Seaton (1995)
10.1007/S11051-005-9001-5
Biodistribution and tumor uptake of C60(OH)x in mice
Z. Ji (2006)
Mesotelioma: il ruolo delle fibre ultrafini e conseguenti riflessi in campo preventivo e medico legale [Mesothelioma: the role of ultrafine fibers and consequences for prevention and legal medicine
G Chiappino (2005)
10.1007/S11051-007-9211-0
Multi-criteria decision analysis and environmental risk assessment for nanomaterials
I. Linkov (2007)
Characterising the potential risks posed by engineered nanoparticles
DEFRA (2006)
Nanotechnology and the need for risk governance.
W. Bijker (2007)
10.1080/15287390306435
Rejoinder: Reanalysis of the Harvard Six Cities Study and American Cancer Society Study of Particulate Air Pollution and Mortality
D. Krewski (2003)
10.1021/ES062629T
Exposure of engineered nanoparticles to human lung epithelial cells: influence of chemical composition and catalytic activity on oxidative stress.
Ludwig K. Limbach (2007)
10.2131/JTS.33.105
Induction of mesothelioma in p53+/- mouse by intraperitoneal application of multi-wall carbon nanotube.
A. Takagi (2008)
10.1289/ehp.749215
Passage of particles through the wall of the gastrointestinal tract
G. Volkheimer (1974)
10.1289/EHP.02110797
Evidence that ultrafine titanium dioxide induces micronuclei and apoptosis in Syrian hamster embryo fibroblasts.
Q. Rahman (2002)
10.1073/PNAS.96.9.5177
Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery.
W. Godbey (1999)
Nano” safety recall [web site
K Bulls (2006)
10.1016/J.CARBON.2008.03.003
Particle exposure levels during CVD growth and subsequent handling of vertically-aligned carbon nanotube films
D. Bello (2008)
10.1186/1743-8977-2-10
Combustion-derived nanoparticles: A review of their toxicology following inhalation exposure
K. Donaldson (2005)
The rate of progression of poliomyelitis virus in nerves
D Bodian (1941)
An association between airpollution and mortality in 6 United-States cities
DW Dockery (1993)
Pulmonary Instillation Studies with Nanoscale TiO2 Rods and Dots in Rats: Toxicity is not dependent upon Particle Size and Surface Area
DuPont Haskell Lab (2006)
10.1183/09031936.03.00402403
Elderly humans exposed to concentrated air pollution particles have decreased heart rate variability
R. Devlin (2003)
10.1289/EHP.9652
Reviewing the environmental and human health knowledge base of carbon nanotubes.
A. Helland (2008)
10.1080/15459620802059393
Engineering Case Reports
Leo Old (2008)
Experimental Studies on Intraneural Spread of Poliomyelitis Virus.
D. Bodian (1941)
10.1080/00984100290071649
TRANSLOCATION OF ULTRAFINE INSOLUBLE IRIDIUM PARTICLES FROM LUNG EPITHELIUM TO EXTRAPULMONARY ORGANS IS SIZE DEPENDENT BUT VERY LOW
W. Kreyling (2002)
10.1038/nnano.2008.111
Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study.
Craig A. Poland (2008)
10.1016/S0887-2333(02)00041-3
Quantitative determination of OH radical generation and its cytotoxicity induced by TiO(2)-UVA treatment.
T. Uchino (2002)
No small matter II: the case for a global moratorium
ETC Group (2003)
10.1515/REVEH.2007.22.2.115
Is air pollution a cause of cardiovascular disease? Updated review and controversies
R. Brook (2007)
10.1515/REVEH.2008.23.4.243
A Systematic Review of the Relation Between Long-term Exposure to Ambient Air Pollution and Chronic Diseases
M. Goldberg (2008)
10.1002/JPS.2600730934
Distribution and elimination of polymethyl methacrylate nanoparticles after peroral administration to rats.
M. Nefzger (1984)
10.1002/9780470715369.CH9
The Olfactory Neuron and the Blood‐Brain Barrier
A. D. Lorenzo (2008)
10.3109/10611860108997929
Interaction of Poly(butylcyanoacrylate) Nanoparticles with the Blood-Brain Barrier in vivo and in vitro
R. N. Alyaudtin (2001)
10.1016/S0014-5793(96)01431-7
Adsorption to silica nanoparticles of human carbonic anhydrase II and truncated forms induce a molten‐globule‐like structure
P. Billsten (1997)
10.1161/01.CIR.103.23.2810
Increased Particulate Air Pollution and the Triggering of Myocardial Infarction
A. Peters (2001)
10.1289/ehp.7339
Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles
G. Oberdörster (2005)
Nanotechnology: a research strategy for addressing risk
AD Maynard (2006)
10.1289/ehp.9297193
Role of the alveolar macrophage in lung injury: studies with ultrafine particles.
G. Oberdörster (1992)
Herpes simplex encephalitis.
P. C. Porcopis (1981)
10.1021/ES072598H
Formulating the problems for environmental risk assessment of nanomaterials.
R. Owen (2007)
Engineered nanoparticles: Review of health and environmental safety (ENRHES). Project Final Report
V. Stone (2010)
10.1016/S0006-291X(02)00445-X
Cellular localisation of a water-soluble fullerene derivative.
Sarah Foley (2002)
What do we (need to) know about the kinetic properties of nanoparticles in the body? Regulatory Toxicology and Pharmacology, 49:217–229
Hagens (2007)
10.1186/1743-8977-3-11
The potential risks of nanomaterials: a review carried out for ECETOC
P. Borm (2006)
10.1080/15287390490253688
Exposure to Carbon Nanotube Material: Aerosol Release During the Handling of Unrefined Single-Walled Carbon Nanotube Material
A. Maynard (2004)
Magic nano” product recall update
AD Maynard (2006)
10.1016/j.tox.2007.12.022
Oxidative stress induced by cerium oxide nanoparticles in cultured BEAS-2B cells.
E. Park (2008)
10.1021/nl801661w
Reproducible comet assay of amorphous silica nanoparticles detects no genotoxicity.
Clifford A Barnes (2008)
10.1080/08958370490439597
Translocation of Inhaled Ultrafine Particles to the Brain
G. Oberdörster (2004)
10.1016/S0169-409X(01)00142-9
Caveolae as potential macromolecule trafficking compartments within alveolar epithelium.
M. Gumbleton (2001)
10.1093/TOXSCI/KFJ197
Correlating nanoscale titania structure with toxicity: a cytotoxicity and inflammatory response study with human dermal fibroblasts and human lung epithelial cells.
C. Sayes (2006)
10.1016/0378-4274(96)03752-6
Free radical activity associated with the surface of particles: a unifying factor in determining biological activity?
K. Donaldson (1996)
10.1007/s11192-007-0310-6
Measuring and assessing the development of nanotechnology
A. Hullmann (2007)
Getting nanotechnology right the first time
JM Balbus (2005)
10.1080/15459620802050053
Measurement of the Physical Properties of Aerosols in a Fullerene Factory for Inhalation Exposure Assessment
Y. Fujitani (2008)
10.1161/01.CIR.0000108927.80044.7F
Cardiovascular Mortality and Long-Term Exposure to Particulate Air Pollution: Epidemiological Evidence of General Pathophysiological Pathways of Disease
C. Pope (2004)
10.1046/j.1365-2818.2000.00672.x
Particulate Matter: Properties and Effects upon Health.
Brown (2000)
NanoFrontiers: visions for the future of nanotechnology
K Schmidt (2007)
10.1080/17435390902944069
The known unknowns of nanomaterials: Describing and characterizing uncertainty within environmental, health and safety risks
Khara Grieger (2009)
10.1164/RCCM.200205-399OC
Ultrafine particle deposition and clearance in the healthy and obstructed lung.
J. Brown (2002)
10.1164/AJRCCM.164.9.2101036
Passage of intratracheally instilled ultrafine particles from the lung into the systemic circulation in hamster.
A. Nemmar (2001)
10.1186/1477-3155-2-12
Nanoparticles – known and unknown health risks
P. Hoet (2004)
10.1016/J.TIV.2005.06.034
In vitro toxicity of nanoparticles in BRL 3A rat liver cells.
S. Hussain (2005)
10.1073/pnas.0608582104
Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles
T. Cedervall (2007)
10.21236/ada440025
Developing Experimental Approaches for the Evaluation of Toxicological Interactions of Nanoscale Materials
B. Moudgil (2004)
10.1016/J.TIV.2005.08.008
The in vitro absorption of microfine zinc oxide and titanium dioxide through porcine skin.
A. Gamer (2006)
Small is Different : A Science Perspective on the Regulatory Challenges of the Nanoscale July 2008 REPORT IN FOCUS
W. Chan
10.1179/107735207800245036
The Role of Asbestos Fiber Dimensions in the Prevention of Mesothelioma
L. Tomatis (2007)
10.1021/es101202a
Infiltration of outdoor ultrafine particles into a test house.
D. H. Rim (2010)
10.1080/15459620802590058
Airborne Monitoring to Distinguish Engineered Nanomaterials from Incidental Particles for Environmental Health and Safety
T. Peters (2009)
10.1021/NL061025K
Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm.
T. Xia (2006)
10.1080/10611860290031877
Apolipoprotein-mediated Transport of Nanoparticle-bound Drugs Across the Blood-Brain Barrier
J. Kreuter (2002)
10.1021/BC9801272
Molecular chaperone-like activity of hydrogel nanoparticles of hydrophobized pullulan: thermal stabilization with refolding of carbonic anhydrase B.
K. Akiyoshi (1999)
10.1021/ES048729L
Cytotoxicity of carbon nanomaterials: single-wall nanotube, multi-wall nanotube, and fullerene.
G. Jia (2005)
10.1016/j.tins.2006.02.002
Selective stabilization and synaptic specificity: a new cell-biological model
J. Jontes (2006)
10.1098/rsta.2000.0670
The chemical composition of atmospheric ultrafine particles
G. Cass (2000)
Draft report of FSA regulatory review
FSA (2006)
Human Respiratory Tract Model for Radiological Protection
Icrp (1994)
10.1111/j.1348-0421.2004.tb03621.x
Quantum Dots Targeted to the Assigned Organelle in Living Cells
Akiyoshi Hoshino (2004)
10.1089/089426802320282338
The pulmonary toxicology of ultrafine particles.
K. Donaldson (2002)
10.1016/J.PROGPOLYMSCI.2007.05.014
Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.
A. Kabanov (2007)
10.1007/978-1-4020-9491-0_1
Human Health Risks of Engineered Nanomaterials
A. Elder (2009)
10.1023/B:PHAM.0000019302.26097.cc
3H Dendrimer Nanoparticle Organ/Tumor Distribution
Shraddha S. Nigavekar (2004)
10.1289/ehp.7021
Manufactured Nanomaterials (Fullerenes, C60) Induce Oxidative Stress in the Brain of Juvenile Largemouth Bass
E. Oberdörster (2004)
10.2217/17435889.3.5.703
Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats.
M. Longmire (2008)
10.1016/0304-4165(86)90020-6
Pinocytosis and phagocytosis: the effect of size of a particulate substrate on its mode of capture by rat peritoneal macrophages cultured in vitro.
M. Pratten (1986)
10.1183/09031936.00178308
Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and granuloma
Y. Song (2009)
10.1098/rsta.2000.0680
Toxicology of ultrafine particles: in vivo studies
Güunter Oberdürster (2000)
A review of completed and near completed environment, health and safety research on nanomaterials and nanotechnology
DEFRA (2009)
10.1007/S10856-007-3296-Y
Single walled carbon nanotubes (SWCNT) affect cell physiology and cell architecture
J. Kaiser (2008)
10.1080/17435390701727509
Categorization framework to aid hazard identification of nanomaterials
Steffen Foss Hansen (2007)
10.1016/S0887-2333(98)00050-2
The role of oxidative stress in the prolonged inhibitory effect of ultrafine carbon black on epithelial cell function.
V. Stone (1998)
FY 2009 budget and highlights
NNI (2009)
Preliminary analysis of exposure measurement and exposure mitigation in occupational settings: manufactured nanomaterials
OECD (2009)
10.1038/labinvest.3700054
Rapid method for measurement of surface tension in multiwell plates
M. Cottingham (2004)
10.1078/1438-4639-00123
The surface area rather than the surface coating determines the acute inflammatory response after instillation of fine and ultrafine TiO2 in the rat.
D. Höhr (2002)
10.1002/9781444307504.CH10
Risk Assessment of Manufactured Nanomaterials
S. Rocks (2009)
Meta-analysis of time series studies and panel studies of particulate matter (PM) and ozone (O3). Report of a WHO task group
R. Atkinson (2004)
Small sizes that matter: opportunities and risks of nanotechnologies
Allianz (2005)
10.1007/978-94-015-9101-0_12
Standardization as a Trust Device
W. Halffman (1998)
10.1161/01.CIR.0000013838.94747.64
Inhalation of Fine Particulate Air Pollution and Ozone Causes Acute Arterial Vasoconstriction in Healthy Adults
R. Brook (2002)
10.1080/00984100290071658
EXTRAPULMONARY TRANSLOCATION OF ULTRAFINE CARBON PARTICLES FOLLOWING WHOLE-BODY INHALATION EXPOSURE OF RATS
G. Oberdörster (2002)
NANOTECHNOLOGIES – PART 2: GUIDE TO SAFE HANDLING AND DISPOSAL OF MANUFACTURED NANOMATERIALS
(2013)
10.1021/CEN-V085N046.P029
CARBON NANOTUBES BY THE METRIC TON
A. Thayer (2007)
10.1159/000066249
Penetration of Titanium Dioxide Microparticles in a Sunscreen Formulation into the Horny Layer and the Follicular Orifice
J. Lademann (1999)
10.1080/009841099157160
Mechanism of silica- and titanium dioxide-induced cytotoxicity in alveolar macrophages.
J. Kim (1999)
10.1016/J.YEXCR.2004.12.021
Formation of nucleoplasmic protein aggregates impairs nuclear function in response to SiO2 nanoparticles.
Min Chen (2005)
10.1093/TOXSCI/40.2.220
Intratracheal inhalation vs intratracheal instillation: differences in particle effects.
M. Osier (1997)
10.1177/030098589703400607
Regression of Pulmonary Lesions Produced by Inhaled Titanium Dioxide in Rats
R. Baggs (1997)
10.1111/j.1365-2796.2009.02187.x
Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology
G. Oberdörster (2010)
10.1289/EHP.929747
Transport of particles of colloidal gold within and from rat lung after local deposition by alveolar microinjection.
G. Patrick (1992)
Fifth Ministerial Conference on Environment and Health
WHO Regional Office for Europe (2008)
10.1111/j.1440-0960.1996.tb01050.x
A pilot study on the percutaneous absorption of microfine titanium dioxide from sunscreens
M. H. Tan (1996)
10.1080/08958370801915309
Hazard and risk assessment of a nanoparticulate cerium oxide-based diesel fuel additive - a case study.
B. Park (2008)



This paper is referenced by
10.1111/risa.12470
Foresight Study on the Risk Governance of New Technologies: The Case of Nanotechnology.
Sheona A. K. Read (2016)
Release of nanomaterials from consumer products and implications for consumer exposure assessment
A. Mackevica (2016)
10.1002/em.22177
Conventional and novel “omics”‐based approaches to the study of carbon nanotubes pulmonary toxicity
C. Ventura (2018)
10.1680/JCOMA.16.00011
Nanomaterials in construction – what is being used, and where?
W. Jones (2019)
Regulating nanoparticles : a complex balancing act
Sylvia Isabelle Sarah Dean (2016)
Engineered Nanomaterials for Pharmaceutical and Biomedical Products New Trends, Benefits and Opportunities
A. Valavanidis (2016)
Responsibility, regulation and the construction of markets of nanotechnologies in food and food packaging : the cases of Canada and India
Rumana Bukht (2016)
Precarious Promise: A Case Study of Engineered Carbon Nanotubes
M. Jacobs (2014)
Journal of Nanotechnology and Materials Science
Shilpi Srivastava (2016)
10.33720/KISGD.456185
İş Sağlığı ve Güvenliği Kapsamında Nanomateryal Risk Değerlendirmesi
İbrahim Eyi (2018)
Engineered Nanoparticle (Eco)Toxicity: Towards Standardized Procedures for Hazard Identification
Denisa Cupi (2015)
10.1016/j.scitotenv.2015.09.112
Environmental risk assessment of chemicals and nanomaterials--The best foundation for regulatory decision-making?
Kristian Syberg (2016)
10.1061/(ASCE)HZ.2153-5515.0000247
Researching Risks of Nanomaterials in Mexico
E. Lau (2016)
10.1016/B978-0-444-62747-6.00010-5
Risk Management and Surveillance of Nanomaterials for Public Health
M. Tyshenko (2015)
10.12691/JAP-7-1-1
Cerium Levels in Coarse and Fine Airborne Particulate Matter in El Paso, Texas, U.S.A.
E. A. Fumador (2019)
10.3109/17435390.2015.1132346
Release of nanomaterials from solid nanocomposites and consumer exposure assessment – a forward-looking review
A. Mackevica (2016)
10.2174/1381612821666150901103208
Nanotechnology in Drug Delivery: Safety and Toxicity Issues.
K. Jain (2015)
10.1007/978-3-030-05846-3_1
Nanobiotechnology at a Glance
Hoda Jafarizadeh-Malmiri (2019)
10.1007/s10111-016-0397-8
Revisiting the technologies of the old: a case study of cognitive work analysis and nanomaterials
Vivek Kant (2016)
10.1007/S11569-015-0245-Y
DPSIR and Stakeholder Analysis of the Use of Nanosilver
S. Hansen (2015)
10.3390/ijerph120808717
Inventory of Engineered Nanoparticle-Containing Consumer Products Available in the Singapore Retail Market and Likelihood of Release into the Aquatic Environment
Yuanyuan Zhang (2015)
10.1080/17435390.2020.1786185
Nano-safety research lessons for dealing with aerosol transmissions of COVID-19
M. Riediker (2020)
10.1007/978-3-319-50932-7_11
Overcoming Nanomaterial Uncertainties: A Responsive Governance Framework
J. Schenten (2017)
10.1007/s11051-013-2195-z
NanoRiskCat: a conceptual tool for categorization and communication of exposure potentials and hazards of nanomaterials in consumer products
S. Hansen (2013)
Determinants of market uptake of innovation in a situation of uncertainty about environmental and health risks : From BPA to nanotechnology
M. Ostapchuk (2017)
10.25258/ijddt.v9i3.24
Detection of combination effect of silver nanoparticles prepared with Pimpinella anisum and some antibiotics on some pathogenic bacteria
Hussein A. R. Abbood (2019)
10.15407/BIOTECH10.03.007
TOXIC EFFECTS OF NANOPARTICLES
N. Leonenko (2017)
10.1016/j.jhazmat.2016.03.067
The release of silver nanoparticles from commercial toothbrushes.
A. Mackevica (2017)
10.1136/jech-2014-204019
Adequate and anticipatory research on the potential hazards of emerging technologies: a case of myopia and inertia?
S. Hansen (2014)
10.1007/s10111-015-0344-0
Engaging nanotechnology: ethnography of lab-on-a-chip technology in small-scale fluidics research
Vivek Kant (2015)
10.3762/bjnano.8.101
Needs and challenges for assessing the environmental impacts of engineered nanomaterials (ENMs)
Michelle Romero-Franco (2017)
10.1016/B978-0-323-32889-0.00016-9
Role of Nanogenotoxicology Studies in Safety Evaluation of Nanomaterials
H. Louro (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar